Edward van der Horst
2023
In 2023, Edward van der Horst earned a total compensation of $739.1K as Chief Scientific Officer at Sensei Biotherapeutics, a 13% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $230,200 |
|---|---|
| Option Awards | $82,962 |
| Salary | $382,667 |
| Stock Awards | $25,311 |
| Other | $17,942 |
| Total | $739,082 |
der Horst received $382.7K in salary, accounting for 52% of the total pay in 2023.
der Horst also received $230.2K in non-equity incentive plan, $83K in option awards, $25.3K in stock awards and $17.9K in other compensation.
Rankings
In 2023, Edward van der Horst's compensation ranked 1,543rd out of 2,983 executives tracked by ExecPay. In other words, der Horst earned more than 48.3% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 1,543 out of 2,983 | 48th |
Division Manufacturing | 904 out of 1,637 | 45th |
Major group Chemicals And Allied Products | 584 out of 906 | 36th |
Industry group Drugs | 568 out of 869 | 35th |
Industry Pharmaceutical Preparations | 403 out of 627 | 36th |
Source: SEC filing on April 29, 2024.
der Horst's colleagues
We found two more compensation records of executives who worked with Edward van der Horst at Sensei Biotherapeutics in 2023.